You may call RenovaCare, Inc. toll-free using the phone number at the bottom of each web page: 1-888-398-0202, or you may send an email using our contact form.

Yes, RenovaCare, Inc. is a next-generation developer of medical devices, autologous stem cell therapies, and wound care products, publicly traded under the ticker symbol: RCAR on the OTCQB exchange in the USA.

Please see below for the following options: RCAR common shares can only be purchased through a registered investment advisor, stockbroker, or financial services firm and/or bank that provides share brokerage services. Shares may not be purchased directly through the Company at this time. Should you or your broker require additional information, kindly contact RenovaCare Investor Relations at 1-888-398-0202 or by using our website contact form to reach us. Investor education information is available through the Securities and Exchange Commission’s Office of Investor Education at sec.gov, or on our SEC Filings page via: sec-filings

RenovaCare’s CUSIP number is 75988J106.

RenovaCare’s ISIN is US75988J1060.

RenovaCare’s transfer agent is Worldwide Stock Transfer, LLC. The transfer agent is able to assist investors who have misplaced, lost, or destroyed share certificates. Should you or your broker need to get in touch with RenovaCare’s transfer agent, kindly refer to the contact information below:

Worldwide Stock Transfer, LLC

One University Plaza, Suite 505

Hackensack, NJ 07601

Phone: (201) 820-2008

Fax: (201) 820-2010

Email: info@wwstr.com

RenovaCare’s quarterly fiscal reporting periods are as listed below:

Q1 January 1 through March 31

Q2 April 1 through June 30

Q3 July 1 through September 30

Q4 October 1 through December 31

RenovaCare’s fiscal year ends December 31

RenovaCare, Inc. was first incorporated as American Alliance Corporation. in the State of Nevada, effective June 30, 1997. The new Company name became effective on January 7, 2014.

RenovaCare routinely files financial reports and discloses financial information as per legal requirements stipulated by the Securities Exchange Commission (SEC). The Company’s filings may be viewed on this web site’s ‘SEC Filings’ section or at the SEC web site at https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001016708.